C
Cipher Pharmaceuticals Inc. CPH.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Weiss Ratings CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Rating C
Reward Index Good
Risk Index Fair
Risk Grade C
Reward Grade B-
Rating Factors CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Fair
Efficiency Index Excellent
Solvency Index Excellent
Total Return Index Fair
Volatility Index Fair
Beta / Standard Deviation CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.52
Price History CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -0.41%
30-Day Total Return -13.43%
60-Day Total Return -18.49%
90-Day Total Return -22.06%
Year to Date Total Return -15.30%
1-Year Total Return 70.46%
2-Year Total Return 218.95%
3-Year Total Return 537.89%
5-Year Total Return 1,378.05%
52-Week High % Change -42.66%
52-Week Low % Change 69.27%
Price CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $19.69
52-Week Low Price $6.67
52-Week Low Price (Date) Mar 15, 2024
52-Week High Price (Date) Aug 29, 2024
Valuation CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 200.80M
Enterprise Value 230.12M
Price/Earnings (TTM) 17.82
Earnings Per Share (TTM) 0.63
Earnings Per Share Growth -49.60%
Price/Earnings To Growth --
Price/Sales (TTM) 10.96
Price/Book (Q) 2.92
Enterprise Value/Revenue (TTM) 8.70
Price $12.12
Enterprise Value/EBITDA (TTM) 18.30
Enterprise Value/EBIT 23.28
Market Cap Category Micro Cap
Dividends and Shares CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 25.69M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 905 602 5840
Address 5750 Explorer Drive Mississauga, ON L4W 0A9
Website www.cipherpharma.com
Country Canada
Year Founded 2000
Profitability CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) 37.34%
Profit Margin 59.92%
Management Effectiveness CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets 5.06%
Return on Equity 17.98%
Income Statement CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 26.46M
Total Revenue (TTM) 26.46M
Revenue Per Share $1.03
Gross Profit (TTM) 21.38M
EBITDA (TTM) 12.57M
EBIT (TTM) 9.88M
Net Income (TTM) 15.86M
Net Income Avl. to Common (TTM) 15.86M
Total Revenue Growth (Q YOY) 70.90%
Earnings Growth (Q YOY) -95.97%
EPS Diluted (TTM) 0.63
EPS Diluted Growth (Q YOY) -96.30%
Balance Sheet CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 9.52M
Cash Per Share (Q) $0.37
Total Current Assets (Q) 29.06M
Total Preferred Equity (Q) --
Total Equity (Q) 98.86M
Current Ratio (Q) 2.003
Book Value Per Share (Q) $3.86
Total Assets (Q) 153.86M
Total Current Liabilities (Q) 14.51M
Total Debt (Q) 40.75M
Total Liabilities (Q) 55.00M
Total Common Equity (Q) 98.86M
Cash Flow CPH.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -80.18M
Cash from Financing (TTM) 34.46M
Net Change in Cash (TTM) -32.56M
Levered Free Cash Flow (TTM) -78.71M
Cash from Operations (TTM) 13.08M
Weiss Ratings